<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">31424791</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK545207</ArticleId></ArticleIdList><Book><Publisher><PublisherName>StatPearls Publishing</PublisherName><PublisherLocation>Treasure Island (FL)</PublisherLocation></Publisher><BookTitle book="statpearls">StatPearls</BookTitle><PubDate><Year>2022</Year><Month>01</Month></PubDate><BeginningDate><Year>2022</Year><Month>01</Month></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="statpearls" part="article-21943">Apocrine Miliaria</ArticleTitle><Language>eng</Language><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>Litchman</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Sonthalia</LastName><ForeName>Sidharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>SKINNOCENCE: The Skin Clinic</Affiliation></AffiliationInfo></Author></AuthorList><PublicationType UI="D000072643">Study Guide</PublicationType><Abstract><AbstractText>Fox-Fordyce disease (FFD), an eponym for apocrine miliaria, is a rare chronic inflammatory skin disorder of the apocrine glands characterized by a pruritic papular eruption in the apocrine gland-rich parts of the body, including the axillae, areolae, anogenital region, among others. This disorder was first described in 1902 by George Henry Fox and John Addison Fordyce as pruritic papules in the axillae. Since then, it has been seen in the other aforementioned apocrine gland containing regions. FFD has a female predominance, and the mainstay of diagnosis is clinical evaluation. Treatment is challenging, as there is a paucity of research in this area, but it is often necessary secondary to prominent pruritus. There are multiple treatment options, including topical, systemic, and surgical, although topical medicines remain the initial treatment of choice.</AbstractText><CopyrightInformation>Copyright © 2022, StatPearls Publishing LLC.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s1">Continuing Education Activity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s2">Introduction</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s3">Etiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s4">Epidemiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s5">Pathophysiology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s6">Histopathology</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s7">History and Physical</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s8">Evaluation</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s9">Treatment / Management</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s10">Differential Diagnosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s11">Pertinent Studies and Ongoing Trials</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s12">Prognosis</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s13">Complications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s14">Deterrence and Patient Education</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s15">Pearls and Other Issues</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s16">Enhancing Healthcare Team Outcomes</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s17">Review Questions</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-21943" sec="article-21943.s18">References</SectionTitle></Section></Sections><ContributionDate><Year>2022</Year><Month>5</Month><Day>8</Day></ContributionDate><ReferenceList><Reference><Citation>Barber HW. Case of Fox-Fordyce Disease. Proc R Soc Med. 1922;15(Dermatol Sect):44-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2103274</ArticleId><ArticleId IdType="pubmed">19982255</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ML, Harford RR, Yeager JK. Fox-Fordyce disease treated with topical clindamycin solution. Arch Dermatol. 1995 Oct;131(10):1112-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">7574824</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiotoku MM, Lopes PT, Marques ME, Marques SA, Miot HA. Fox-Fordyce disease in monozygotic female twins. J Am Acad Dermatol. 2011 Jul;65(1):229-30.</Citation><ArticleIdList><ArticleId IdType="pubmed">21679831</ArticleId></ArticleIdList></Reference><Reference><Citation>GRAHAM JH, SHAFER JC, HELWIG EB. Fox-Fordyce disease in male identical twins. Arch Dermatol. 1960 Aug;82:212-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">13828810</ArticleId></ArticleIdList></Reference><Reference><Citation>Scroggins L, Kelly E, Kelly B. Fox-Fordyce disease in daughter and father. Dermatology. 2009;218(2):176-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19060475</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner TW. Hormonal levels in Fox-Fordyce disease. Br J Dermatol. 1976 Mar;94(3):317-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1252362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sammour R, Nasser S, Debahy N, El Habr C. Fox-Fordyce Disease: An under-diagnosed adverse event of laser hair removal? J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1578-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">27135989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernad I, Gil P, Lera JM, Giménez de Azcárate A, Irarrazaval I, Idoate MÁ. Fox Fordyce disease as a secondary effect of laser hair removal. J Cosmet Laser Ther. 2014 Jun;16(3):141-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">24131099</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetzlaff MT, Evans K, DeHoratius DM, Weiss R, Cotsarelis G, Elenitsas R. Fox-Fordyce disease following axillary laser hair removal. Arch Dermatol. 2011 May;147(5):573-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21576577</ArticleId></ArticleIdList></Reference><Reference><Citation>Helou J, Maatouk I, Moutran R, Obeid G. Fox-Fordyce-like disease following laser hair removal appearing on all treated areas. Lasers Med Sci. 2013 Jul;28(4):1205-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23318918</ArticleId></ArticleIdList></Reference><Reference><Citation>Shackelton J, English JC. Fox-Fordyce Disease (Apocrine Miliaria). J Pediatr Adolesc Gynecol. 2011 Jun;24(3):108-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21751451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada A, Saga K, Jimbow K. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. J Am Acad Dermatol. 2003 Mar;48(3):453-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12637930</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazganoğlu KD, Yazici S, Büyükbabani N, Ozkaya E. Axillary Fox-Fordyce-like disease induced by laser hair removal therapy. J Am Acad Dermatol. 2012 Oct;67(4):e139-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22980266</ArticleId></ArticleIdList></Reference><Reference><Citation>CORNBLEET T. Pregnancy and apocrine gland diseases: hidradenitis, Fox-Fordyce disease. AMA Arch Derm Syphilol. 1952 Jan;65(1):12-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14877283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebling FJ. Apocrine glands in health and disorder. Int J Dermatol. 1989 Oct;28(8):508-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">2684877</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega-Memije ME, Pérez-Rojas DO, Boeta-Ángeles L, Valdés-Landrum P. Fox-Fordyce disease: report of two cases with perifollicular xanthomatosis on histological image. An Bras Dermatol. 2018 Jul-Aug;93(4):562-565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063129</ArticleId><ArticleId IdType="pubmed">30066765</ArticleId></ArticleIdList></Reference><Reference><Citation>Brau Javier CN, Morales A, Sanchez JL. Histopathology attributes of Fox-Fordyce disease. Int J Dermatol. 2012 Nov;51(11):1313-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23067079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bormate AB, Leboit PE, McCalmont TH. Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases. Arch Dermatol. 2008 Aug;144(8):1020-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">18711075</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco-Morente G, Naranjo-Díaz MJ, Pérez-López I, Martínez-López A, Ruiz-Villaverde R, Aneiros-Fernández J. Fox-Fordyce Disease. Sultan Qaboos Univ Med J. 2016 Feb;16(1):e119-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4746034</ArticleId><ArticleId IdType="pubmed">26909204</ArticleId></ArticleIdList></Reference><Reference><Citation>In vivo features of Fox-Fordyce disease in high-definition optical coherence tomography. J Dtsch Dermatol Ges. 2016 Mar;14(3):340.</Citation><ArticleIdList><ArticleId IdType="pubmed">26972218</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WC, Cao T, Ho MS, Chong WS, Lee JS. In vivo features of Fox-Fordyce disease in high-definition optical coherence tomography. J Dtsch Dermatol Ges. 2016 Jan;14(1):62-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26713641</ArticleId></ArticleIdList></Reference><Reference><Citation>George A, Bhatia A, Thomas E. Fox-Fordyce disease: a report of 2 cases responding to topical clindamycin. Indian J Dermatol Venereol Leprol. 2015 Jan-Feb;81(1):87-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25566917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Erdoğan H, Bulur I, Kaya Z. Clinical Effects of Topical Tacrolimus on Fox-Fordyce Disease. Case Rep Dermatol Med. 2015;2015:205418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4485495</ArticleId><ArticleId IdType="pubmed">26171257</ArticleId></ArticleIdList></Reference><Reference><Citation>Milcic D, Nikolic M. Clinical effects of topical pimecrolimus in a patient with Fox-Fordyce disease. Australas J Dermatol. 2012 May;53(2):e34-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22571582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pock L, Svrcková M, Machácková R, Hercogová J. Pimecrolimus is effective in Fox-Fordyce disease. Int J Dermatol. 2006 Sep;45(9):1134-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16961542</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacobetti R, Caro WA, Roenigk HH. Fox-Fordyce disease. Control with tretinoin cream. Arch Dermatol. 1979 Nov;115(11):1365-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">507892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassuga LE, Medrado MM, Chevrand NS, Salles Sde A, Vilar EG. Fox-Fordyce disease: response to adapalene 0.1%. An Bras Dermatol. 2012 Mar-Apr;87(2):329-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22570049</ArticleId></ArticleIdList></Reference><Reference><Citation>Effendy I, Ossowski B, Happle R. Fox-Fordyce disease in a male patient--response to oral retinoid treatment. Clin Exp Dermatol. 1994 Jan;19(1):67-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8313643</ArticleId></ArticleIdList></Reference><Reference><Citation>Han HH, Lee JY, Rhie JW. Successful treatment of areolar Fox-Fordyce disease with surgical excision and 1550-nm fractionated erbium glass laser. Int Wound J. 2016 Oct;13(5):1016-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7949813</ArticleId><ArticleId IdType="pubmed">27072751</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzuncakmak TK, Karadag AS, Ozlu E, Akdeniz N, Cobanoglu Simsek B. Effective treatment of Fox-Fordyce disease with pulsed dye laser. Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):311-313.</Citation><ArticleIdList><ArticleId IdType="pubmed">27623097</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Ramos J, Alonso-Pacheco ML, Goiburú-Chenú B, Mayor-Ibarguren A, Herranz-Pinto P. Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A. Br J Dermatol. 2016 Feb;174(2):458-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Al-Qarqaz F, Al-Shannag R. Fox-Fordyce disease treatment with fractional CO2 laser. Int J Dermatol. 2013 Dec;52(12):1571-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24261728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae KM, Marschall MA, Marschall SF. Axillary Fox-Fordyce disease treated with liposuction-assisted curettage. Arch Dermatol. 2002 Apr;138(4):452-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11939804</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor D, Au J, Boen M, Fox S, Aronson IK, Jacob C. A novel modality using microwave technology for the treatment of Fox-Fordyce disease (FFD). JAAD Case Rep. 2016 Jan;2(1):1-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4809446</ArticleId><ArticleId IdType="pubmed">27051811</ArticleId></ArticleIdList></Reference><Reference><Citation>Roga G, Bhat I. Axillary syringomas mimicking Fox-Fordyce disease. Indian Dermatol Online J. 2015 Sep-Oct;6(5):376-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4594413</ArticleId><ArticleId IdType="pubmed">26500884</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan R, Bang D, Nagar A, Bilimoria F. Rare sweat gland tumors of vulva: Report of two cases. Indian J Sex Transm Dis AIDS. 2012 Jul;33(2):124-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3505290</ArticleId><ArticleId IdType="pubmed">23188940</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosrati N, Coleman NM, Hsu S. Axillary syringomas. Dermatol Online J. 2008 Apr 15;14(4):13.</Citation><ArticleIdList><ArticleId IdType="pubmed">18627735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelati A, Aqil N, Mernissi FZ. Dermoscopic Findings and Their Therapeutic Implications in Trichostasis Spinulosa: A Retrospective Study of 306 Patients. Skin Appendage Disord. 2018 Oct;4(4):291-295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6219231</ArticleId><ArticleId IdType="pubmed">30410899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabiri S, Pourazizi M, Abtahi-Naeini B. Can Fractionated Microneedle Radiofrequency be an Effective Procedure for Treatment of Fox-Fordyce Disease? A Medical Hypothesis. Adv Biomed Res. 2018;7:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5952534</ArticleId><ArticleId IdType="pubmed">29862220</ArticleId></ArticleIdList></Reference><Reference><Citation>Naeini FF, Saffaei A, Pourazizi M, Abtahi-Naeini B. Histopathological evidence of efficacy of microneedle radiofrequency for treatment of axillary hyperhidrosis. Indian J Dermatol Venereol Leprol. 2015 May-Jun;81(3):288-90.</Citation><ArticleIdList><ArticleId IdType="pubmed">25851757</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo KY, Yoon MS, Kim DH, Lee HJ. Skin rejuvenation by microneedle fractional radiofrequency treatment in Asian skin; clinical and histological analysis. Lasers Surg Med. 2012 Oct;44(8):631-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22936274</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31424791</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
